Hong Kan, PhD

Advisor
Eli Lilly and Company

Poster(s):

• (151) Modelling Total Healthcare Cost Offsets and Treatment Costs Associated with Treating Adults with Obesity with Tirzepatide and Semaglutide in US Clinical Practice Settings
  Wednesday, October 29, 2025